Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Methods of inhibiting MASP-2 for the treatment and/or prevention of coronavirus-induced acute respiratory distress syndrome

Methods of inhibiting MASP-2 for the treatment and/or prevention of coronavirus-induced acute respiratory distress syndrome

US Patent 12351648 · Granted Jul 8, 2025

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Anti-inflammatory and mydriatic intracameral solutions for inhibition of postope2024
Stable preservative-free mydriatic and anti-inflammatory solutions for injection2024
Methods for inhibiting fibrosis in a subject in need thereof2024
Methods for inhibiting angiogenesis in a subject in need thereof2024
Methods for treating conditions associated with MASP-2 dependent complement acti2024
Methods for treating and/or preventing graft-versus-host disease and/or diffuse 2024
Antibodies specifically binding to MASP-3 for the treatment of various diseases 2024
Methods for treating conditions associated with MASP-2 dependent complement acti2024
Highly concentrated low viscosity MASP-2 inhibitory antibody formulations, kits,2023
Methods of inhibiting MASP-2-dependent complement activation in a subject suffer2022
Treatment of addiction and impulse-control disorders using PDE7 inhibitors2022
Anti-inflammatory and mydriatic intracameral solutions for inhibition of postope2022